Literature DB >> 6736183

Quantification of tiazofurin in plasma by high-performance liquid chromatography.

R W Klecker, J M Collins.   

Abstract

A simple and sensitive method was developed for the separation and quantification of tiazofurin ( TCAR ) in plasma using 2-beta-D- ribofuranosylthiazole -5-carboxamide (iso- TCAR ) or [5-3H] TCAR as an internal standard. The procedure uses C18 extraction columns to clean-up the plasma samples for measurement by high-performance liquid chromatography. A sensitivity of 0.33 microM (0.08 microgram/ml) was easily achieved for 0.5-ml plasma samples. When human whole blood was incubated in vitro with TCAR for 2 h, the plasma concentrations were decreased by 10% (4 degrees C) and 25% (23 degrees C). TCAR could still be measured 22 h after injection of 220 mg/kg into mice. For a two-compartment pharmacokinetic model, the half-lives of TCAR were 18.8 and 412 min.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6736183     DOI: 10.1016/s0378-4347(00)84107-9

Source DB:  PubMed          Journal:  J Chromatogr


  2 in total

1.  Phase I and pharmacokinetic study of tiazofurin (TCAR, NSC 286193) administered by continuous infusion.

Authors:  G Batist; R W Klecker; H N Jayaram; J F Jenkins; J Grygiel; D C Ihde; J L Eddy; R L Fine; I G Kerr; J M Collins
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

2.  Clinical pharmacology of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide, NSC 286193).

Authors:  R M Green; D J Stewart; J A Maroun
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.